ArticleScientific reports2025
Enhancing the growth and essential oil components of Lavandula latifolia using Malva parviflora extract and humic acid as biostimulants in a field experiment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- The Role of Plant-Derived Essential Oils in Eco-Friendly Crop Protection Strategies Under Drought and Salt Stress.Plants (Basel, Switzerland) · 2025Review
- The effect of humic acid in composition with polyacrylamide copolymers on wind and water soil erosion.Scientific reports · 2025Article
- Genomics control of biostimulant-induced stress tolerance and crop yield enhancement.The Plant journal : for cell and molecular biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural extracts as biostimulants have the potential to enhance the productivity and growth of many medicinal and aromatic plants. This study aimed to enhance the growth, and essential oil (EO) content, as well as composition of Lavandula latifolia Medik. by using Malva parviflora L. extract (ME) as a biostimulant in combination with humic acid (HA) in a field experiment in two successive seasons of 2022 and 2023. The phenolic, flavonoid and water-soluble vitamins of the ME were analyzed using an HPLC. The protein amino acids of the ME were identified by an amino acid analyzer. The prepared concentrations of HA (0, 1, 2, and 4 g/L) were applied to the soil. While, they for ME (0, 2, 4, and 6 g/L) were added as a foliar spray. The EO compositions collected from the leaves of the treated L. latifolia plants were subjected to the hydro-distillation method and analyzed using GC-MS. The most prevalent vitamins found in ME were vitamin B12, vitamin C, and folic acid. Besides, several phenolic compounds were found in ME, such as catechol, cinnamic acid and syringic acid, while flavonoid chemicals, such as luteolin and quercetin. Also, alanine, ammonia, aspartic acid, glutamic acid, glycine, and tyrosine were the ME's most prominent nitrogenous and amino acid components. The most effective treatments of HA and ME on the plant height, the number of branches/plant, and plant fresh weight were 4 + 6 g/L and 4 + 2 g/L for leaf area and chlorophyll content, it was 4 + 4 g/L; and for EO percentage were 4 + 0 g/L, 2 + 0 g/L, and 4 + 4 g/L, compared to the control treatment for each characteristic. The main EO compounds eucalyptol, camphor, α-pinene, β-pinene, Δ-elemene, germacrene D-4-ol, isoborneol, β-caryophyllene oxide, and tau.-cadinol identified in the leaves were found in the range of 28.74-46.19%, 15.34-30.49%, 3.39-7.16%, 0-5.08%, 0-5.18%, 0-3.20%, 0-3.31% and 0-3.40%, respectively. It can be concluded that a combination treatment of HA and ME as natural biostimulant compounds at 4 + 4 g/L could be recommended for good plant growth, and EO quantity of L. latifolia plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.